• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.31% Nasdaq Up0.98%

    Lexicon Pharmaceuticals, Inc. (LXRX)

    -NasdaqGS
    0.92 0.02(1.97%) Jan 29, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 419   676   277   1,410  
    Cost of Revenue -   -   -   -  
    Gross Profit 419   676   277   1,410  
    Operating Expenses
    Research Development24,108  21,187  23,953  20,263  
    Selling General and Administrative3,545  5,600  6,796  (1,877)
    Non Recurring13,102   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (40,336) (26,111) (30,472) (16,976)
    Income from Continuing Operations
    Total Other Income/Expenses Net287  538  94  39  
    Earnings Before Interest And Taxes(40,049)(25,573)(30,378)(16,937)
    Interest Expense449  455  457  477  
    Income Before Tax(40,498)(26,028)(30,835)(17,414)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(40,498)(26,028)(30,835)(17,414)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (40,498) (26,028) (30,835) (17,414)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (40,498) (26,028) (30,835) (17,414)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.